Gupta VK, Pannu D, Singh MP, Kumar L. Effect of SGLT-2 inhibitor (remogliflozin) plus DPP4 inhibitor (vildagliptin) on diabetic nephropathy in patients with type 2 diabetes mellitus comparison with combination of metformin and sulphonylureas. Int J Adv Med [Internet]. 2023 May 25 [cited 2025 Nov. 16];10(6):446-51. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/3839